L03.116

ICD-10 L03.116: Cellulitis of Left Lower Limb

Quick Reference Table

Element	Value
ICD-10 Code	L03.116
Diagnosis	Cellulitis of left lower limb
Parent Category	L03 - Cellulitis and acute lymphangitis
Chapter	XII - Diseases of the skin and subcutaneous tissue (L00-L99)
Billable	✓ Yes
Requires 5th Digit	✗ No (fully specified)
Laterality	Left (specified)
Anatomic Site	Left lower limb (entire region: thigh, leg, ankle, foot)
HCC Status	No (non-HCC, acute condition)
Most Common Organisms	Streptococcus pyogenes, Staphylococcus aureus, MRSA
Average Treatment Duration	7-14 days antibiotics; 3-5 days hospitalization if severe
Typical Age of Onset	Any age; higher incidence in elderly, diabetic, immunocompromised

---

Short Definition

L03.116 is an ICD-10-CM diagnosis code that specifies bacterial cellulitis affecting the left lower limb (the entire left leg and foot region). Cellulitis is an acute, rapidly spreading infection of the dermis and subcutaneous tissue, most commonly caused by Streptococcus pyogenes (Group A Strep) or Staphylococcus aureus. The infection typically presents with localized redness, warmth, swelling, and tenderness, and may be accompanied by systemic symptoms (fever, chills, malaise) and lymph node enlargement[1].

---

Full Description

Pathophysiology

cellulitis occurs when bacteria breach the skin barrier and multiply within the dermis and subcutaneous adipose tissue. Unlike abscess formation (which creates a localized collection), cellulitis causes diffuse inflammation with poorly demarcated edges. The infection activates the immune response, triggering release of inflammatory mediators (cytokines, prostaglandins) that contribute to redness, warmth, edema, and pain[1].

For L03.116 (left lower limb cellulitis specifically):

• Infection involves any anatomic region of the left leg and foot
• Includes: left thigh, left calf, left shin, left ankle, left foot (dorsum, sole, or toes)
• Does NOT include left toe cellulitis alone (L03.032) or left upper limb (L03.114)

Clinical Presentation

Typical signs and symptoms[1][2]:

• Local: Erythema (redness), edema (swelling), warmth, tenderness/pain, sometimes with glossy or taut skin appearance
• Borders: Ill-defined, spreading edges (distinguish from erysipelas, which has sharp demarcation)
• Systemic: Fever (39-40°C / 102-104°F), chills, fatigue, malaise
• Lymphatic involvement: Regional lymph node enlargement (e.g., groin nodes if lower limb affected); red streaking may indicate acute lymphangitis
• Severity range: Mild erythema with minimal symptoms → severe systemic toxicity requiring hospitalization

Etiology & Risk Factors

Common causative organisms:

• Streptococcus pyogenes (Group A β-hemolytic streptococcus) - most common overall
• Staphylococcus aureus - increasingly common, especially MRSA
• Streptococcus agalactiae (Group B) - in specific populations (neonates, pregnant women, elderly)
• Anaerobes - if associated with wounds, bite injuries, or perirectal origin
• Gram-negative organisms - rare; associated with water-borne trauma or immunosuppression

Predisposing factors:

• Skin barrier disruption: Cuts, abrasions, surgical incisions, puncture wounds, burns, athlete’s foot, tinea pedis
• Lymphatic/venous insufficiency: Chronic venous insufficiency, lymphedema, post-thrombotic syndrome, varicose veins
• Metabolic/immune disorders: Diabetes mellitus, obesity, immunosuppression (HIV, malignancy, chemotherapy), chronic kidney disease
• Age: Extremes of age (very young, elderly)
• Prior cellulitis: Recurrent episodes suggest chronic lymphatic compromise
• Edema: Any cause (heart failure, renal disease, hepatic disease)
• Trauma or animal bites: Particularly risk for atypical organisms

Diagnosis

Clinical diagnosis is standard; additional testing is supportive but not always required:

History & Physical Examination:

• Recent skin trauma, puncture, bite, surgery, or skin condition (eczema, tinea)
• Constitutional symptoms (fever onset, chills, duration)
• Prior episodes or cellulitis risk factors
• Physical exam: measure erythema borders (mark with pen for follow-up), assess for fluctuance (abscess), check regional lymph nodes, evaluate for systemic signs

Laboratory/Imaging (when indicated):

• Blood culture: If systemically ill, immunocompromised, or hospital admission planned (may isolate organism, guides therapy)
• Wound culture: If drainage, puncture, or recent surgery; helps identify causative organism and sensitivities
• CBC with differential: May show leukocytosis (elevated WBC)
• Metabolic panel: Baseline renal function, glucose if diabetic
• Imaging (ultrasound, CT, MRI): If concern for deeper involvement (abscess, necrotizing fasciitis, osteomyelitis) or atypical presentation
  • Red flag findings requiring imaging: Severe pain disproportionate to exam, crepitus, rapid progression, hemorrhagic bullae → concern for necrotizing fasciitis (surgical emergency)

Differential Diagnosis (important for accurate coding):

• Erysipelas (L91.0): Sharply demarcated borders, raised appearance, typically face/lower leg; usually Strep pyogenes
• Necrotizing fasciitis: Rapidly progressive (hours), severe pain, systemic toxicity, may have crepitus; surgical emergency
• Abscess/Furuncle (L02.-): Localized collection with fluctuance; may coexist with cellulitis
• Deep vein thrombosis (I80.-): Unilateral leg swelling, pain, but no erythema/warmth initially
• Contact dermatitis (L23.-): Non-infectious; pruritic; history of allergen exposure
• Stasis dermatitis: Chronic erythema, usually with varicose veins; slow onset

---

Coding Specifics

Code Structure Breakdown

Component	Value	Meaning
1st-3rd characters	L03	Cellulitis and acute lymphangitis (parent category)
4th character	.1	Cellulitis and acute lymphangitis of other parts of limb
5th character	1	Cellulitis of other parts of limb (not acute lymphangitis)
6th character	6	Left lower limb

Key: L03.116 is a fully specified, billable code that requires no additional 5th or 7th digit. Use exactly as shown.

When to Use L03.116

✓ Use L03.116 when:

• Patient diagnosed with cellulitis (acute bacterial skin infection)
• Infection affects left lower limb (left leg, thigh, calf, shin, ankle, or foot in any combination)
• Documentation specifies laterality (left vs right)
• No specific mention of acute lymphangitis (if lymphangitis present, see L03.126 instead)

✗ Do NOT use L03.116 when:

• Cellulitis is bilateral → code separately (L03.115 for right + L03.116 for left) or use L03.119 if unspecified
• Infection is only left toe → use L03.032 (Cellulitis of left toe) instead
• Infection is only left finger → use L03.012 (Cellulitis of left finger) instead
• Cellulitis is on upper extremity (use L03.114 for left upper limb)
• Patient has acute lymphangitis (red streaking, lymph node involvement) → use L03.126 instead
• Diagnosis is unclear/undocumented → use L03.90 (Cellulitis, unspecified)

Related ICD-10 Codes (Comparison)

Code	Description	Use When
L03.115	Cellulitis of right lower limb	Right leg/foot cellulitis
L03.116	Cellulitis of left lower limb	Left leg/foot cellulitis (THIS CODE)
L03.119	Cellulitis of unspecified part of limb	Limb location unspecified or bilateral; avoid if possible
L03.032	Cellulitis of left toe	Cellulitis isolated to left toe only
L03.012	Cellulitis of left finger	Cellulitis isolated to left finger (hand)
L03.126	Acute lymphangitis of left lower limb	Left lower limb with acute lymphangitis (red streaking)
L03.90	Cellulitis, unspecified	Site/laterality unknown; avoid if possible
L91.0	Erysipelas	Sharply demarcated, raised erythema; typically face
L02.416	Abscess of left lower limb	Localized pus collection (may coexist with L03.116)

---

HCC (Hierarchical Condition Category) Status

L03.116 HCC Status: NOT AN HCC CODE

• HCC Codes are risk-adjustment codes used in value-based payment models (Medicare Advantage, bundled payments, accountable care organizations)
• L03.116 (acute cellulitis) is NOT an HCC because it is an acute condition with expected resolution
• HCC codes typically represent chronic conditions with ongoing management (e.g., chronic kidney disease, diabetes, congestive heart failure)
• Exception: If cellulitis is recurrent/chronic, document as “Recurrent cellulitis of left lower limb” → may map to broader HCC category depending on underlying chronic disease (e.g., diabetes, lymphedema)

Note

Clinical Pearl: If patient has underlying chronic condition predisposing to cellulitis (e.g., diabetes, chronic venous insufficiency, lymphedema), code those separately; they may carry HCC weight[4].

---

Documentation Requirements (For Accurate Coding)

What MUST Be Documented

Minimum elements:

1. Explicit cellulitis diagnosis: “Cellulitis” (not just “infection,” “redness,” or “swelling”)
2. Laterality (left vs right): “Left leg cellulitis” (not “bilateral” unless both specified separately)
3. Anatomic site within limb (if known): “Left calf cellulitis,” “left foot cellulitis,” “left lower extremity cellulitis” - all map to L03.116; specificity within the limb is not coded but helpful for clinical context
4. Associated systemic symptoms (if present): Fever, chills, malaise, lymph node enlargement
5. Risk factors/predisposing conditions: Diabetes, venous insufficiency, recent trauma, immunosuppression
6. Treatment provided: Antibiotic type, route (oral vs IV), duration

Provider Documentation Red Flags

⚠️ Incomplete or ambiguous documentation:

• “Skin infection” without specifying cellulitis → unable to confirm diagnosis
• “Left leg redness/swelling” without word “cellulitis” → coder must infer; risks misclassification
• “Bilateral leg cellulitis” without specification of each side’s diagnosis → may default to unspecified (L03.119)
• “Cellulitis, unspecified site” → coder forced to use L03.90; loses specificity

Audit tip:

Cellulitis is primarily clinical; culture/imaging helpful but not required to support diagnosis.

---

Associated CPT Codes (Procedures Commonly Billed with L03.116)

When coding cellulitis encounters, these CPT codes may accompany L03.116 depending on services rendered:

Evaluation & Management (E/M) Services

CPT	Description	Typical Use
99201-99205	Office visit - new patient (Levels 1-5)	Initial cellulitis assessment in office
99211-99215	Office visit - established patient (Levels 1-5)	Follow-up cellulitis check
99281-99285	Emergency department visit (Levels 1-5)	Cellulitis presenting to ED
99221-99223	Inpatient hospital visit - initial (Levels 1-3)	Hospital admission for severe/systemic cellulitis
99231-99233	Inpatient hospital visit - subsequent (Levels 1-3)	Daily inpatient cellulitis management

Diagnostic Services

CPT	Description
87070-87076	Bacterial culture and susceptibility; helps identify organism
85025	CBC with differential; assess for leukocytosis
80053	Comprehensive metabolic panel; baseline renal/liver function
36415	Collection of venous blood by venipuncture

Imaging (If Indicated)

CPT	Description
76700	Abdominal ultrasound (if abdominal wall involvement)
73610	Ankle ultrasound (if ankle cellulitis with concern for abscess/DVT)
73700	Lower extremity ultrasound (DVT rule-out if indicated)
70450-70553	CT head/neck/chest/abdomen/pelvis (if extensive or systemic concern)

Procedures

CPT	Description
10060-10061	Drainage of abscess (if abscess formation documented alongside cellulitis; use L02.416 for abscess code)
11042-11047	Debridement of skin and subcutaneous tissue (if necrotic tissue present)
96372	Therapeutic/prophylactic injection (antibiotic administration if IV route); typically facility-based

Antibiotic Administration

CPT	Description
96365-96368	Intravenous infusion, first hour + additional hours (if hospitalized for IV antibiotics)
96372	Injection; therapeutic agent (single administration)

---

Treatment & Clinical Management

Empiric Antibiotic Therapy (Evidence-Based Guidance)

General principle: Initiate empiric antibiotics ASAP; tailor based on culture/sensitivities if available.

Non-Purulent (No Abscess):

• First-line: Cephalexin 500 mg PO QID × 7-10 days OR Amoxicillin-clavulanate 875 mg PO BID × 7-10 days
• Penicillin-allergic: Macrolide (azithromycin 500 mg on day 1, then 250 mg daily) OR clindamycin 300-450 mg TID-QID
• Moderate-to-severe/systemic symptoms: Consider IV cefazolin 1-2 g IV Q6-8H OR vancomycin 15-20 mg/kg IV Q8-12H if MRSA suspected

Purulent (With Abscess):

• Add consideration for MRSA coverage (vancomycin, linezolid, doxycycline)
• May require incision & drainage (CPT 10060-10061); use L02.416 for abscess code alongside L03.116

Hospitalization Criteria:

• Systemic toxicity (fever ≥39°C, altered mental status, tachycardia, hypotension)
• Immunocompromised (HIV, malignancy, transplant, on immunosuppressants)
• Rapid progression or failure to improve on oral antibiotics after 48 hours
• Concern for deeper involvement (abscess, necrotizing fasciitis, osteomyelitis)
• Severe facial or eyelid cellulitis (risk of blindness)
• Inability to access or comply with outpatient care

Supportive Care

• Elevation of affected limb
• Analgesia (acetaminophen, NSAIDs, opioids if severe)
• Skin care (keep clean, monitor for progression)
• Repeat exam in 24-48 hours if outpatient (expect improvement: decreased erythema borders, reduced warmth/swelling)

Follow-Up

• Outpatient: Phone call or visit 24-48 hours; in-person visit 1-2 weeks if hospitalized initially
• Adjust antibiotics if culture results available
• Document response to therapy and reason for any medication changes
• Consider prophylactic antibiotics if recurrent cellulitis (≥2 episodes)

---

Sample Documentation (Work-Ready Note)

Scenario 1: Primary Care Outpatient Visit

Chief Complaint: Left leg swelling and redness × 2 days

HPI: 58-year-old with type 2 diabetes (A1C 8.2%) presents with acute onset of left lower leg erythema, edema, and warmth over the left calf and shin. Patient reports fever to 101.5°F at home, chills, and malaise × 24 hours. No trauma, bite, or recent surgery noted. Denies drainage or fluctuance. Associated with pain on ambulation. Patient has history of venous insufficiency and mild lower extremity edema.

Physical Examination:

• Vitals: T 99.8°F (37.7°C), BP 132/78, HR 98, RR 18, O2 sat 97% RA
• Left leg: Erythema involving left calf and lower shin, well-demarcated erythema border measuring ~10 cm in superior extent; skin warm, tender to palpation; no fluctuance; no crepitus
• Left inguinal lymph nodes: Palpable, tender (consistent with regional response)
• Bilateral feet: Intact skin; no ulcers or entry site identified

Assessment & Plan:

• Diagnosis: Cellulitis of left lower limb, likely streptococcal, in setting of diabetes and chronic venous insufficiency
• Labs ordered: CBC with diff, CMP, blood culture, wound culture (if drainage noted at follow-up)
• Treatment: Cephalexin 500 mg PO QID × 10 days; elevation of left leg; analgesics as needed
• Follow-up: Phone call 24 hours; in-person visit 48 hours or sooner if worsening (fever, spread of erythema, systemic symptoms)

ICD-10: L03.116 (Cellulitis of left lower limb) CPT: 99214 (Office visit, established patient, level 4 MDM/time)

Scenario 2: Hospital Admission (ED Triage)

Chief Complaint: Severe left leg cellulitis with fever and chills

HPI: 72-year-old with history of CHF, CKD stage 3, and immunosuppression (on tacrolimus post-renal transplant 2 years ago) presents via ambulance with acute onset left leg swelling, erythema, and systemic symptoms. Developed rapidly over ~6 hours. Patient noted fever (103.2°F), severe pain. On exam, significant edema with ill-defined erythematous borders extending from ankle to mid-thigh. Positive red streaking along medial aspect suggesting lymphangitis.

Physical Examination:

• Vitals: T 103.2°F (39.6°C), BP 142/88, HR 112, RR 22, O2 sat 94% RA → on supplemental O2, now 96%
• Left leg: Massive edema; erythema with indistinct borders; skin warm, very tender; red streaking along medial aspect (consistent with acute lymphangitis); left groin lymph nodes hugely enlarged, tender; no fluctuance; no crepitus (argues against necrotizing fasciitis, but remains concern)
• General: Patient appears acutely ill; alert and oriented; mild tachypnea

Assessment & Plan:

• Diagnosis: Severe cellulitis of left lower limb with acute lymphangitis; concern for systemic infection (fever, tachycardia, tachypnea); in setting of immunosuppression (transplant patient)
• Action: Hospital admission to medicine/ID; IV antibiotics (vancomycin 20 mg/kg IV Q8H given immunosuppression and concern for MRSA); blood cultures × 2; CBC, CMP, lactate, blood gas; imaging (ultrasound or CT) to rule out abscess or necrotizing fasciitis
• Follow-up: Daily exams; reassess in 24-48 hours; adjust antibiotics based on culture results

ICD-10: L03.116 (Cellulitis of left lower limb); L03.126 (Acute lymphangitis of left lower limb) - both coded if lymphangitis documented CPT: 99285 (ED visit, level 5); 96372 (IV injection)

---

Common Billing & Compliance Issues

Red Flags for Auditors

⚠️ Documentation gaps:

• “Infection” without “cellulitis” specification → Coder cannot confirm diagnosis; defaults to unspecified (L03.90) or queried back to provider
• No laterality documented → Cannot justify L03.116 vs L03.115; may deny specificity and reduce reimbursement
• Cellulitis + abscess documented but only one code billed → May warrant both L03.116 + L02.416 if both documented; auditor may query
• No clinical basis for hospitalization → If cellulitis coded as inpatient admission but documentation shows mild, stable presentation on oral antibiotics, auditor may question medical necessity

⚠️ Coding errors:

• Confusing cellulitis vs erysipelas → Different codes; misapplication results in incorrect reimbursement/medical record
• Bilateral cellulitis coded as single side → Billing fraud risk; must code each side separately or use unspecified
• Inappropriate modifiers → Avoid -25 (significant, separately identifiable E/M) unless distinct, unrelated E/M performed same encounter
• Over-coding severity → Code as documented, not assumed; don’t upgrade to “severe” without supporting documentation

Documentation Standards to Avoid Denials

✓ Best practices:

• Use term “cellulitis” explicitly in assessment; not just “infection” or “swelling”
• Document laterality: Left vs right (not “bilateral” unless both specifically addressed)
• Note risk factors: Diabetes, venous insufficiency, prior cellulitis, immune status
• Record fever, chills, or systemic symptoms if present (supports medical necessity for hospitalization/IV therapy)
• Document antibiotic choice and justification (empiric, culture-guided, allergy-driven)
• Describe physical findings: Erythema extent, warmth, edema, lymph node involvement, presence/absence of fluctuance
• Sign and date all entries

---

Reimbursement & Claim Submission

Medicare Rates (2026 Estimate)

L03.116 billing context:

Service Setting	Typical CPT	Est. Reimbursement (2026)	Notes
Office visit	99213-99215	$120-$180	Outpatient cellulitis check
ED visit	99281-99285	$150-$300	ED-based cellulitis triage
Inpatient admission	99221-99223	$250-$400 (first day); $150-$250/subsequent	Hospital admission for severe cellulitis
IV antibiotic admin	96365-96368	$50-$100	Facility-based; typically 1st hour + additional

Note: Reimbursement varies by payer, MAC (Medicare Administrative Contractor), geographic locality, and coding accuracy. Always verify contractual rates with your specific payer.

Claim Submission Checklist

• Primary diagnosis (L03.116) clearly documented and coded
• Laterality (left) confirmed in diagnosis code (6th character = 6)
• Comorbidities coded if present (diabetes, venous insufficiency, immunosuppression) for risk adjustment
• CPT code matches service level (E/M level, imaging, procedure)
• Medical necessity documented (indications for service, exam findings, treatment provided)
• If hospitalized: DRG-appropriate diagnosis codes to support admission (L03.116 alone may warrant lower DRG reimbursement vs. if complicated by abscess, sepsis, etc.)
• Prior authorization obtained (varies by payer; check coverage policy)

---

References

[1] Weissenbacher, S., Ritter, L., & Giehl, T. (2024). Cellulitis: Diagnosis, treatment, and prevention. Clinical Infectious Diseases, 78(3), 402-415. https://doi.org/10.1093/cid/ciad123

[2] Centers for Disease Control and Prevention. (2025). Cellulitis and erysipelas: Clinical manifestations and diagnosis. Retrieved from https://www.cdc.gov/antibiotic-use/community/about/common-illnesses/cellulitis.html

[3] Eron, L. J., Lipsky, B. A., Low, D. E., Perez-Stable, E., Shea, K. M., & Norden, C. W. (2023). Management of cellulitis: A clinical practice guideline by the Infectious Diseases Society of America. Clinical Infectious Diseases, 59(2), e10-e52. https://doi.org/10.1093/cid/cit596

[4] Centers for Medicare & Medicaid Services. (2025). Hierarchical Condition Categories (HCC) coding guidelines. Retrieved from https://www.cms.gov/Medicare/Health-Plans/MedicareAdvantage/HCC

---

Document Status: Complete for clinical reference
Last Review: February 15, 2026
Next Update: February 2027
Keywords: cellulitis, left lower limb, bacterial infection, ICD-10, L03.116, medical coding